GW&K Investment Management LLC Decreases Stock Position in Healthpeak Properties, Inc. $DOC

GW&K Investment Management LLC lowered its stake in Healthpeak Properties, Inc. (NYSE:DOCFree Report) by 5.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,563,613 shares of the real estate investment trust’s stock after selling 94,583 shares during the period. GW&K Investment Management LLC’s holdings in Healthpeak Properties were worth $25,143,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of DOC. Integrated Wealth Concepts LLC increased its holdings in shares of Healthpeak Properties by 7.3% in the first quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after buying an additional 1,231 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Healthpeak Properties by 110.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock worth $2,463,000 after buying an additional 63,930 shares during the period. Woodline Partners LP increased its holdings in shares of Healthpeak Properties by 41.3% in the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock worth $1,195,000 after buying an additional 17,279 shares during the period. Brown Advisory Inc. increased its holdings in Healthpeak Properties by 3.1% during the 2nd quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after purchasing an additional 1,415 shares during the period. Finally, Qube Research & Technologies Ltd purchased a new position in Healthpeak Properties during the 2nd quarter valued at about $3,117,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Down 0.1%

Shares of NYSE:DOC opened at $20.47 on Thursday. Healthpeak Properties, Inc. has a 1 year low of $15.70 and a 1 year high of $20.81. The company has a market cap of $14.11 billion, a PE ratio of 63.98, a P/E/G ratio of 3.21 and a beta of 1.05. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. The stock’s 50-day moving average is $18.18 and its 200 day moving average is $17.45.

Healthpeak Properties (NYSE:DOCGet Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. During the same quarter in the previous year, the business earned $0.46 EPS. Healthpeak Properties’s revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.74 EPS for the current year.

Healthpeak Properties Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be issued a dividend of $0.1017 per share. The ex-dividend date is Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 6.0%. Healthpeak Properties’s dividend payout ratio is 381.25%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on DOC shares. Robert W. Baird boosted their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. Weiss Ratings upgraded Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Wells Fargo & Company boosted their price target on Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a report on Monday, June 1st. Scotiabank boosted their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a report on Wednesday, May 27th. Finally, UBS Group boosted their price target on Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a report on Wednesday, May 13th. Four research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, Healthpeak Properties currently has a consensus rating of “Hold” and an average target price of $19.38.

Get Our Latest Stock Analysis on Healthpeak Properties

Insider Buying and Selling at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. This represents a 59.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.23% of the company’s stock.

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

See Also

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOCFree Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.